BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7540878)

  • 21. The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits.
    Zawilska K; Zozulinska M; Turowiecka Z; Blahut M; Drobnik L; Vinazzer H
    Thromb Res; 1993 Feb; 69(3):315-20. PubMed ID: 8475480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
    Koyama T; Kakishita E; Nakai Y; Okamoto E
    Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases].
    Ohmoto K; Yamamoto S; Ideguchi S; Yamamoto R; Takatori K; Ohumi T; Hino K; Hirano Y
    Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1837-45. PubMed ID: 2147451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
    Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
    Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
    Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
    Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
    Okajima K; Sakamoto Y; Uchiba M
    Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
    Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
    Dickneite G; Czech J; Keuper H
    Circ Shock; 1994 Apr; 42(4):183-9. PubMed ID: 8055664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia.
    Sunder-Plassmann G; Speiser W; Korninger C; Stain M; Bettelheim P; Pabinger-Fasching I; Lechner K
    Ann Hematol; 1991 May; 62(5):169-73. PubMed ID: 2049463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment.
    Chojnowski K; Wawrzyniak E; Treliński J; Niewiarowska J; Cierniewski C
    Leuk Lymphoma; 1999 Dec; 36(1-2):77-84. PubMed ID: 10613452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
    Kobayashi T; Terao T
    Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lepirudin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
    Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemostatic study before onset of disseminated intravascular coagulation.
    Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi A; Mori Y; Deguchi K
    Am J Hematol; 1993 Jul; 43(3):190-4. PubMed ID: 8352234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endotoxin-induced disseminated intravascular coagulation in rabbits: effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality.
    Hermida J; Montes R; Páramo JA; Rocha E
    J Lab Clin Med; 1998 Jan; 131(1):77-83. PubMed ID: 9452130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J; Brüggener E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
    Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
    Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.